Albert Bourla, Pfizer CEO (Photographer: Michael Nagle/Bloomberg via Getty Images)
Can the Pfizer machine fight back against an activist investor?
Pfizer says it’s back on track.
After a tumultuous 2024 filled with more cost cuts, an activist investor, a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
